Govt Job: For Assistant Professor at NIPER – Salary Rs. 60,000 pm

NIPER, Kolkata, was established in 2007 under the aegis of the Ministry of Chemicals & Fertilizers as a Center of Excellence for higher education, research, and development in pharmaceutical sciences.

The Institute was declared an institute of national importance by the Government of India through an Act of Parliament (NIPER Act 1998 & NIPER amendment Act 2007).

We are proud of preparing dynamic leaders, who make a difference in the world, with the skills that are nurtured here for a better tomorrow.

Post: Assistant Professor in the Department of Pharmaceutical Analysis

Applications are invited from Indian citizens for filling up the post of Assistant Professor in the Department of Pharmaceutical Analysis on a contract basis in NIPER Kolkata

Essential qualifications: M.Pharm. / M.S. (Pharm.) in Pharmaceutical Analysis and a Ph.D. in Analytical Science or another relevant area.

Experience: Candidates with one year or more experience in teaching or conducting research in pharmaceutical analysis / relevant area (excluding the experience gained during their Master’s and Ph.D.). The candidate should be capable of teaching students and carrying out independent research.

Age limit : Not more than 40 years as on the date of advertisement.

Salary: Rs. 60,000/- fixed per month

Terms and conditions
1. The above position is purely contractual and initially for a period of 1 year.

The continuation of the tenure is subject to satisfactory performance and review at the end of the year.

On satisfactory performance, the tenure may be further extended.

2. The selected candidate should work minimum for a period of one year / academic year in the institute.

3. Director reserves the right to modify the conditions or cancellation of the interview.

4. Selected candidates will not be entitled to claim for regular appointment/absorption in the institute.

5. No TA/DA will be paid for attending the interview.

6. Candidates reaching after the specified time may not be entertained.

7. Canvassing in any form will disqualify the candidature.

How to apply
Candidates should apply with their CV, attested copies of relevant certificates/mark sheets, experience certificates, etc. via email to niperkrecruitment2020@gmail.com, with the subject marked as “Application for the post of Assistant Professor on contract”

Last date of receipt of applications: 24th November 2022

Date of the Interview The shortlisted candidates will be informed by email about the interview date.

Related Posts

  • Pharma
  • May 16, 2025
  • 42 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

  • Pharma
  • May 16, 2025
  • 68 views
DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for ‘all types of fevers’, citing violation of the Drugs and Magic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs